Gabriel A. Rabinovich (PhD) is Director of the Laboratory of Glycomedicine at the Institute of Biology and Experimental Medicine, Senior Investigator of the Argentinean National Research Council (CONICET) and Full Professor of Immunology at the Faculty of Exact and Natural Sciences, University of Buenos Aires. He is Member of the US National Academy of Science (NAS), European Molecular Biology Organization (EMBO), Latin American Academy of Science, Third World Academy of Science (TWAS) and Argentinean Academy of Science. He won several prizes and awards including the Karl Meyer Award (Society of Glycobiology), TWAS (Italy), John Simon Guggenheim (USA), Outstanding Investigator of the Nation (Argentina), Bunge & Born, Diamond and Platinum Konex Award and Bernardo Houssay awards, among others. He serves as Associate Editor and/or member of the board of several journals, filed several patents. His laboratory is interested in understanding the function of glycans and glycan-binding proteins in cellular processes relevant to immune regulation in health and disease. Together with his team, he demonstrated that galectins, a family of β-galactoside-binding proteins, can translate glycan-encoded information into novel regulatory programs that control inflammation, suppress autoimmune pathology and allow cancer cells to evade immune responses and promote angiogenesis. His findings opened new therapeutic possibilities in cancer, chronic inflammation and autoimmune diseases. Recently, he co-founded Galtec, a Start-up company aimed at translating galectin-based discoveries into therapeutic strategies for cancer and autoimmune diseases.